Clinical Immunology

Understanding Your Diagnosis: Autoinflammatory Syndrome with Immunodeficiency

At a Glance

Autoinflammatory syndrome with immunodeficiency describes rare immune disorders in which inflammation is overactive while infection defenses are weak. The specific subtype, genetic findings, symptoms, and laboratory results guide specialist care.

Receiving a diagnosis of an autoinflammatory syndrome with immunodeficiency can feel like receiving two contradictory pieces of news at once. It is a complex and paradoxical situation where the immune system is both overactive and underactive simultaneously ^[1]^[2]. One part of your immune system may be in a state of constant, “auto-pilot” inflammation, while another part lacks the necessary tools to defend you from common infections ^[3].

This diagnosis falls under the broad umbrella of Inborn Errors of Immunity (IEI), a group of rare conditions where a genetic change causes the immune system to malfunction ^[1]. It is important to understand that “Autoinflammatory Syndrome with Immunodeficiency” is not a single disease, but a highly variable category that includes several distinct genetic conditions ^[2]. Because these conditions are extremely rare, many local doctors may not have encountered them before; specialized care at an immunology or rheumatology center is often necessary to navigate the complexities of treatment ^[4]^[5].

The Dual Nature of the Immune System

In these syndromes, the immune system’s delicate balance is disrupted. Depending on your subtype, you may experience:

Autoinflammation (Overactive): The “innate” immune system—your body’s first line of defense—acts as if it is under attack even when no infection is present. This leads to symptoms like recurrent fevers, skin rashes, and organ inflammation ^[1]^[6].
Immunodeficiency (Underactive): At the same time, the “adaptive” immune system—which creates antibodies to fight specific germs—or other protective pathways may be weak. This can result in hypogammaglobulinemia (low levels of protective antibodies) and a higher risk of frequent or severe infections ^[3]^[7].

Biologically, this happens because a single genetic mutation can have different effects depending on the cell type. For example, a mutation might cause certain white blood cells to become hyper-responsive and trigger inflammation, while simultaneously impairing other cells’ ability to produce antibodies ^[6].

Common Subtypes and Their Features

While there are many specific conditions within this category, several are more frequently recognized by specialists. Most are monogenic (caused by a single inherited germline gene mutation) and typically begin in childhood, though there are notable exceptions.

Condition	Typical Onset	Primary Features (Examples)
HA20	Early childhood (can vary)	Recurrent oral, genital, or intestinal ulcers; episodic fevers; and potentially low antibody levels ^[8]^[7].
APLAID	Neonatal or early infancy	Blistering skin rashes, recurrent respiratory infections, and inflammation of the eyes or joints ^[9]^[10].
HOIL-1 Deficiency	Infancy or early childhood	Multi-organ inflammation, weak immune response to infections, and amylopectinosis (a buildup of abnormal sugar molecules in muscles) ^[6].
PRAAS-ID	Neonatal or early childhood	An emerging umbrella designation for proteasome-associated syndromes involving severe inflammation of the skin/muscles, with variable immunodeficiency like a lack of B-cells ^[11]^[12].
VEXAS Syndrome	Late adulthood (typically men 50+)	Recurrent fever, skin inflammation, and blood-related issues like low cell counts. Unlike the others, this is a somatic (acquired) disease and is evaluated differently ^[13]^[14].

Challenges in Diagnosis and Care

Patients and caregivers often face a long “diagnostic odyssey” before reaching this conclusion ^[4]. Because symptoms can affect the skin, joints, lungs, and gut, you may have seen several different specialists before an immunologist or geneticist connected the dots ^[15]^[16].

A major hurdle is that the standard treatment for one side of the condition may complicate the other. For instance, medications used to turn down inflammation (immunosuppressants) can further weaken an already struggling immune system, making the risk of infection even higher ^[17]. For this reason, care must be highly personalized, often requiring a “medical home” where experts in genetics, immunology, and rheumatology work together to manage the balance ^[18]^[19]. High-quality genetic testing can be important to identify the most likely subtype, guiding targeted therapies, though a negative test does not exclude the disease ^[20].

Common questions in this guide

What is autoinflammatory syndrome with immunodeficiency?

It is a group of rare immune-system disorders in which the body produces too much inflammation while some of its defenses against infection are weak. It is not one disease; different genetic conditions can cause this combination, so symptoms and treatment vary by subtype.

How can inflammation and immunodeficiency happen at the same time?

A genetic change can make some immune cells overreact and cause inflammation while impairing other cells that make antibodies or fight infections. This can lead to recurrent fevers or rashes alongside frequent or unusually severe infections and low antibody levels.

Which conditions can cause this combination of inflammation and immune weakness?

Examples include HA20, APLAID, HOIL-1 deficiency, and PRAAS-ID. VEXAS syndrome can produce a similar pattern in older adults, but it is an acquired condition rather than an inherited childhood disorder.

How do doctors diagnose an autoinflammatory syndrome with immunodeficiency?

Doctors combine the pattern of inflammatory symptoms, infection history, and laboratory results with evaluation by immunology, rheumatology, or genetics specialists. Genetic testing may help identify a subtype and guide treatment, but a negative result does not completely rule out the condition.

Why might I need care at a specialized immunology center?

These disorders are rare and can affect multiple organs, so many patients need coordinated care from immunology, rheumatology, genetics, and other specialists. A specialized team can help balance inflammation treatment with protection against infections.

How is treatment chosen when inflammation and infection risk coexist?

Treatment is individualized according to the specific subtype, laboratory findings, and balance between inflammatory flares and immune weakness. Medicines that suppress inflammation can increase infection risk, so specialists must carefully weigh treatment benefits against this risk.

Are all autoinflammatory syndromes with immunodeficiency inherited?

Most subtypes are caused by an inherited germline gene mutation. VEXAS syndrome is an important exception because it is an acquired somatic disease that usually begins in later adulthood.

Get notified when new evidence is published on autoinflammatory syndrome with immunodeficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (20)

1
Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.
Aksentijevich I, Schnappauf O
Nature reviews. Rheumatology 2021; (17(7)):405-425 doi:10.1038/s41584-021-00614-1.
PMID: 34035534
2
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC.
Oda H, Beck DB, Kuehn HS, et al.
Frontiers in immunology 2019; (10()):479 doi:10.3389/fimmu.2019.00479.
PMID: 30936877
3
Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency.
Magg T, Okano T, Koenig LM, et al.
Science immunology 2021; (6(60)) doi:10.1126/sciimmunol.abf9564.
PMID: 34145065
4
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations.
Yazdanpanah N, Rezaei N
Expert review of clinical immunology 2024; (20(10)):1237-1259 doi:10.1080/1744666X.2024.2372335.
PMID: 38907993
5
Immune dysregulatory disorders: perspective from solving a diagnostic odyssey.
Crowther L, Broderick L
Current opinion in pediatrics 2026; (38(6)):659-665 doi:10.1097/MOP.0000000000001616.
PMID: 42750655
6
An Update on Autoinflammatory Diseases: Relopathies.
Steiner A, Harapas CR, Masters SL, Davidson S
Current rheumatology reports 2018; (20(7)):39 doi:10.1007/s11926-018-0749-x.
PMID: 29846841
7
A Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment.
Hautala T, Vähäsalo P, Kuismin O, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(8)):e583-e587 doi:10.1097/RHU.0000000000001268.
PMID: 31977656
8
A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.
Aeschlimann FA, Batu ED, Canna SW, et al.
Annals of the rheumatic diseases 2018; (77(5)):728-735 doi:10.1136/annrheumdis-2017-212403.
PMID: 29317407
9
Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa.
Neves JF, Doffinger R, Barcena-Morales G, et al.
Frontiers in immunology 2018; (9()):2863 doi:10.3389/fimmu.2018.02863.
PMID: 30619256
10
Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.
Yang Z, Tao P, Han X, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2024; (76(11)):1670-1678 doi:10.1002/art.42948.
PMID: 38965708
11
Monoallelic PSMB8 variants cause PRAAS with immunodeficiency through impaired immunoproteasome assembly.
Wijngaard R, van der Made CI, Kalkan Uçar S, et al.
American journal of human genetics 2026; (113(6)):1214-1232 doi:10.1016/j.ajhg.2026.04.015.
PMID: 42167218
12
Heterozygous missense variant of the proteasome subunit β-type 9 causes neonatal-onset autoinflammation and immunodeficiency.
Kanazawa N, Hemmi H, Kinjo N, et al.
Nature communications 2021; (12(1)):6819 doi:10.1038/s41467-021-27085-y.
PMID: 34819510
13
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
Beck DB, Ferrada MA, Sikora KA, et al.
The New England journal of medicine 2020; (383(27)):2628-2638 doi:10.1056/NEJMoa2026834.
PMID: 33108101
14
VEXAS syndrome.
Nakajima H, Kunimoto H
International journal of hematology 2025; (122(3)):341-350 doi:10.1007/s12185-024-03799-9.
PMID: 38819628
15
Rheumatologic and Autoimmune Features of Inborn Errors of Immunity: Implications for Diagnosis and Management.
Tobin JM, Cooper MA
Journal of human immunity 2025; (1(3)) doi:10.70962/jhi.20250034.
PMID: 40842819
16
Building alliances for early detection of immunodeficiencies: from primary care to hematology.
Rivière JG, Pasquet M, Gambineri E
Frontiers in immunology 2025; (16()):1701384 doi:10.3389/fimmu.2025.1701384.
PMID: 41550923
17
Case Report: Crossing a rugged road in a primary immune regulatory disorder.
Sgrulletti M, Cifaldi C, Di Cesare S, et al.
Frontiers in pediatrics 2022; (10()):1055091 doi:10.3389/fped.2022.1055091.
PMID: 36699297
18
Disparities in Diagnosis, Access to Specialist Care and Treatment for Inborn Errors of Immunity.
Lawrence MG, Rider NL, Cunningham-Rundles C, Poli MC
The journal of allergy and clinical immunology. In practice 2023; doi:10.1016/j.jaip.2023.10.041.
PMID: 39492552
19
The Inborn Errors of Immunity-Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase.
Coppola E, Sgrulletti M, Cortesi M, et al.
Journal of clinical immunology 2024; (44(2)):47 doi:10.1007/s10875-023-01644-y.
PMID: 38231401
20
Evaluation and pilot testing of a multidisciplinary model of care to mainstream genomic testing for paediatric inborn errors of immunity.
Yanes T, Sullivan A, Barbaro P, et al.
European journal of human genetics : EJHG 2023; (31(10)):1125-1132 doi:10.1038/s41431-023-01321-z.
PMID: 36864115

This page is for informational purposes only and does not replace medical advice. An immunologist, rheumatologist, or geneticist should interpret your symptoms and test results and guide care.